Author:
Fukuyama Y,Yuki Y,Katakai Y,Harada N,Takahashi H,Takeda S,Mejima M,Joo S,Kurokawa S,Sawada S,Shibata H,Park E J,Fujihashi K,Briles D E,Yasutomi Y,Tsukada H,Akiyoshi K,Kiyono H
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference50 articles.
1. Jackson, L.A. & Janoff, E.N. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin. Infect. Dis. 47, 1328–1338 (2008).
2. Nuorti, J.P. & Whitney, C.G. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 59, 1–18 (2010).
3. Oosterhuis-Kafeja, F., Beutels, P. & Van Damme, P. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). Vaccine 25, 2194–2212 (2007).
4. Dagan, R. et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J. Infect. Dis. 185, 927–936 (2002).
5. Dagan, R. et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin. Infect. Dis. 57, 952–962 (2013).
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献